C-Abl inhibition; a novel therapeutic target for Parkinson’s disease
Parkinson’s disease (PD) is the most prevalent movement disorder in the world. The major pathological hallmarks of PD are death of dopaminergic neurons and the formation of Lewy bodies. At the moment, there is no cure for PD; current treatments are symptomatic. Investigators are searching for neu...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English English English |
| Published: |
Bentham Science Publishers B.V.
2018
|
| Subjects: | |
| Online Access: | http://irep.iium.edu.my/58689/ http://irep.iium.edu.my/58689/ http://irep.iium.edu.my/58689/ http://irep.iium.edu.my/58689/1/58689_C-Abl%20inhibition.pdf http://irep.iium.edu.my/58689/2/58689_C-Abl%20inhibition_SCOPUS.pdf http://irep.iium.edu.my/58689/3/58689_C-Abl%20inhibition_WOS.pdf |